pyrrolidonecarboxylic acid has been researched along with oxidopamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, PJ; Lorens, SA; Mitsushio, H; Paris, JM | 1 |
| Sharif, NA | 1 |
| Dyess, EM; Jackson, IM; Kaplan, MM; Lechan, RM; Liposits, Z; Paull, WK; Segerson, TP; Wu, P | 1 |
| Iversen, SD | 1 |
| Kono, T; Makino, I; Nakamura, K; Sato, Y; Tamori, K; Yokohama, S; Yoneda, M | 1 |
| Huston, JP; Nikolaus, S; Schwarting, RK | 1 |
| Glowinski, J; Godeheu, G; Kemel, ML; Pérez, S; Soubrié, P | 1 |
| Makino, I; Nakamura, K; Sato, Y; Terano, A; Yoneda, M | 1 |
| Goto, M; Haneda, M; Hiraishi, H; Nakamura, K; Shimada, T; Terano, A; Yoneda, M | 1 |
| Hiraishi, H; Kono, T; Nakamura, K; Shimada, T; Tamano, M; Watanobe, H; Yoneda, M | 1 |
| Chan, YS; Chen, LW; Chu, JM; Yung, KK | 1 |
1 review(s) available for pyrrolidonecarboxylic acid and oxidopamine
| Article | Year |
|---|---|
Behavioural effects of substance P through dopaminergic pathways in the brain.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Diencephalon; Dopamine; Drug Stability; Endopeptidases; Exploratory Behavior; Hydroxydopamines; Limbic System; Metalloendopeptidases; Motor Activity; Neural Pathways; Neurons; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Substance P; Telencephalon | 1982 |
10 other study(ies) available for pyrrolidonecarboxylic acid and oxidopamine
| Article | Year |
|---|---|
Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
Topics: Animals; Brain; Catheterization; Cerebral Ventricles; Chromatography, High Pressure Liquid; Haloperidol; Hydroxydopamines; Infusions, Parenteral; Male; Motor Activity; Muscimol; Neurons; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Substance P; Tegmentum Mesencephali | 1990 |
Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systems.
Topics: Animals; Binding, Competitive; Choline O-Acetyltransferase; Denervation; Hydroxydopamines; Kainic Acid; Male; Olfactory Bulb; Oxidopamine; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 1988 |
Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus.
Topics: Animals; Gene Expression Regulation; Hydroxydopamines; Hypothyroidism; Immunohistochemistry; Male; Nucleic Acid Hybridization; Oxidopamine; Paraventricular Hypothalamic Nucleus; Protein Precursors; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; RNA, Messenger; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1988 |
Central thyrotropin-releasing hormone stimulates hepatic DNA synthesis in rats.
Topics: Animals; Antibodies; Atropine; Brain; DNA; Injections, Intraventricular; Insulin; Liver; Male; Organ Size; Oxidopamine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Sympathectomy; Thyrotropin-Releasing Hormone; Vagotomy | 1997 |
Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion.
Topics: Animals; Corpus Striatum; Dopamine; Functional Laterality; Male; Motor Activity; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Substance P; Substantia Nigra; Tetragastrin | 1999 |
Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.
Topics: Acetylcholine; Animals; Benzamides; Corpus Striatum; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; In Vitro Techniques; Male; N-Methylaspartate; Neural Inhibition; Neurons; Oxidopamine; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Tachykinin; Substance P; Synaptic Transmission; Tachykinins; Time Factors | 2002 |
Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enzyme Inhibitors; Indomethacin; Injections, Intraventricular; Liver; Liver Diseases; Male; Necrosis; NG-Nitroarginine Methyl Ester; Oxidopamine; Parasympatholytics; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Sympatholytics; Thyrotropin-Releasing Hormone; Vagotomy | 2003 |
Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats.
Topics: Adrenergic Agents; Amylases; Animals; Central Nervous System; Ceruletide; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Male; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Pancreas; Pancreatitis; Peptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone; Time Factors | 2005 |
Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
Topics: Animals; Atropine; Cell Proliferation; Cholinergic Fibers; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Indomethacin; Injections, Intraventricular; Liver; Male; Oxidopamine; Prostaglandins; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Signal Transduction; Thyrotropin-Releasing Hormone; Vagotomy; Vagus Nerve | 2005 |
Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Topics: Analysis of Variance; Animals; Apomorphine; bcl-Associated Death Protein; Caspase 3; Cell Death; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; L-Lactate Dehydrogenase; Male; Motor Activity; Neuroblastoma; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Peptide Fragments; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Rotarod Performance Test; Signal Transduction; Substance P; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase | 2011 |